Enlightenment Research, LLC Bristol Myers Squibb CO Transaction History

Enlightenment Research, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $284,239 - $331,356	-5,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $313,601 - $367,343	5,300 New	5,300 $314,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $705,774 - $768,588	-11,400 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $391,644 - $440,483	6,600 Added 137.5%	11,400 $720,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $277,152 - $314,064	4,800 New	4,800 $298,000
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $827,782 - $967,759	-15,100 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $310,880 - $451,781	6,700 Added 79.76%	15,100 $892,000
Q4 2019 Feb 11, 2020	SELL	$49.21 - $64.19 $113,183 - $147,637	-2,300 Reduced 21.5%	8,400 $539,000
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $457,639 - $542,597	10,700 New	10,700 $543,000
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $1.15 Million - $1.27 Million	-25,800 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $1.16 Million - $1.39 Million	25,800 New	25,800 $1.23 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.